YOUR BUSINESS AUTHORITY
Springfield, MO
Pharmaceutical company GSK reached a $20 million deal with 23andMe Holding Co.
The agreement gives GSK access to DNA data from the approximately 80% of 23andMe gene-testing customers who agreed to share their information for research.
It expands upon an existing five-year deal under which GSK can access anonymized DNA data.
Read more from Bloomberg.
Organizers hope to bolster client traffic to center city businesses.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
State awards Springfield $4.6M for wastewater system improvements
Stockton district names next superintendent
Trump, fast-food companies among targets of X redirects
Council modifies data center definitions bill, extends moratorium into next year